Onabotulinum toxin-A can safely improve sleep bruxism

January 18, 2018

(HealthDay)—Onabotulinum toxin-A (BoNT-A) injections can improve sleep bruxism, according to a study published online Jan. 17 in Neurology.

William G. Ondo, M.D., from the Methodist Neurological Institute in Houston, and colleagues recruited 31 patients aged 18 to 85 years with clinically diagnosed sleep bruxism confirmed by polysomnography. Twenty-three patients were randomized to either BoNT-A injection (13 patients) or placebo (10 ; nine completed the study). Participants were assessed at four to eight weeks after the initial treatment visit.

The researchers found that clinical global impression (P < 0.05) and visual analog scale of change (P < 0.05) in bruxism and in pain favored the BoNT-A group. There was no significant change in any exploratory end points; total sleep time and number/duration of bruxing episodes favored the BoNT-A group. A cosmetic change in smile was reported by two participants randomized to BoNT-A. There were no reports of dysphagia or masticatory adverse events.

"BoNT-A effectively and safely improved sleep in this placebo-controlled pilot trial," the authors write. "A large multicenter trial is needed to confirm these encouraging data."

Two authors disclosed financial ties to Allergan; Allergan Pharmaceuticals funded the study.

Explore further: Botulinum toxin does not cure common forms of neck pain

More information: Abstract
Full Text

Related Stories

Botulinum toxin does not cure common forms of neck pain

July 6, 2011
There is no evidence that Botulinum toxin injections reduce chronic neck pain or associated headaches, says a group of scientists who reviewed nine trials involving a total of 503 participants. Their findings are published ...

Sodium oxybate promising for Parkinson's, daytime sleepiness

November 8, 2017
(HealthDay)—For patients with Parkinson's disease (PD) and excessive daytime sleepiness (EDS), sodium oxybate seems effective and well-tolerated, according to a study published online Nov. 6 in JAMA Neurology.

New botulinum neurotoxin discovered—potential to treat a number of medical conditions

August 3, 2017
Botulinum toxins are currently applicable in more than 80 medical conditions including muscle spasms, overactive bladder, chronic migraine, cervical dystonia, sweating and cerebral palsy (CP). A new toxin, Botulinum neurotoxin ...

Two studies find Botox injections help reduce nighttime teeth grinding

May 1, 2012
(Medical Xpress) -- Two groups working independently have found that patients who suffer from nighttime teeth grinding, a condition known as nocturnal bruxism, found relief after being injected in their temple and jaw muscles ...

Botulinum neurotoxin in plastic surgery—what's the evidence for effectiveness?

August 30, 2016
Botox and other botulinum neurotoxin (BoNT) products are widely known for their use in treating facial wrinkles—but they can also be used to treat a wide range of non-cosmetic problems. Eight conditions with good evidence ...

With Botox 'chemodenervation,' dermal fillers last longer

December 30, 2015
December 30, 2015- Hyaluronic acid (HA) fillers are a popular treatment for facial lines and wrinkles, but early degradation of fillers may limit how long their effects last. Experimental evidence supports a simple technique ...

Recommended for you

Synthetic DNA-delivered antibodies protect against Ebola in preclinical studies

November 13, 2018
Scientists at The Wistar Institute and collaborators have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results, published ...

Scientists illuminate causes of hepatitis B virus-associated acute liver failure

November 13, 2018
National Institutes of Health scientists and their collaborators found that hepatitis B virus (HBV)-associated acute liver failure (ALF)—a rare condition that can turn fatal within days without liver transplantation—results ...

New strategy discovered toward possible prevention of cancers tied to mono, the 'kissing disease'

November 12, 2018
Researchers from the University of Minnesota, the Howard Hughes Medical Institute, and the University of Toronto have discovered a possible path forward in preventing the development of cancers tied to two viruses, including ...

Combination therapy promising against blindness-causing bacterial keratitis

November 12, 2018
Multidrug-resistant bacterial infections of the cornea are a leading cause of blindness and cannot be effectively managed with current ophthalmic antibiotics. A team of investigators has now devised a combination therapy ...

Hepatitis C treatment can be shortened in 50 percent of patients, study finds

November 12, 2018
Hepatitis C drugs cure more than 90 percent of patients, but can cost more than $50,000 per patient.

Salmonella found to be resistant to different classes of antibiotics

November 12, 2018
Brazil's Ministry of Health received reports of 11,524 outbreaks of foodborne diseases between 2000 and 2015, with 219,909 individuals falling sick and 167 dying from such diseases. Bacteria caused most outbreaks of such ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.